1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Cell and Gene Therapy Manufacturing Market
2.2. Global Cell and Gene Therapy Manufacturing Market, By Type, 2023 (US$ Million)
2.3. Global Cell and Gene Therapy Manufacturing Market, By Indication, 2023 (US$ Million)
2.4. Global Cell and Gene Therapy Manufacturing Market, By Application, 2023 (US$ Million)
2.5. Global Cell and Gene Therapy Manufacturing Market, By End User, 2023 (US$ Million)
2.6. Global Cell and Gene Therapy Manufacturing Market, By Geography, 2023 (US$ Million)
2.7. Attractive Investment Proposition by Geography, 2023

3. Cell and Gene Therapy Manufacturing Market: Competitive Analysis
3.1. Market Positioning of Key Cell and Gene Therapy Manufacturing Market Vendors
3.2. Strategies Adopted by Cell and Gene Therapy Manufacturing Market Vendors
3.3. Key Industry Strategies
4. Cell and Gene Therapy Manufacturing Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Cell and Gene Therapy Manufacturing Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Cell and Gene Therapy Manufacturing Market: By Type, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Cell Therapy
5.3.1.1. Allogeneic
5.3.1.1.1. Mesenchymal Stem Cells
5.3.1.1.2. T-cells
5.3.1.1.3. Induced Pluripotent Stem Cells
5.3.1.1.4. Natural Killer Cells
5.3.1.1.5. Hematopoietic Stem Cells
5.3.1.1.6. Other Allogeneic Cells
5.3.1.2. Autologous
5.3.1.2.1. T-cells
5.3.1.2.2. Hematopoietic Stem Cells
5.3.1.2.3. Mesenchymal Stem Cells
5.3.1.2.4. Natural Killer Cells
5.3.1.2.5. Other AutologousCells
5.3.1.3. Viral Vector
5.3.1.3.1. Retroviral Vectors
5.3.1.3.2. Adeno-associated Virus Vectors
5.3.1.3.3. Other Viral Vectors
5.3.2. Gene Therapy
5.3.2.1. Viral Vector
5.3.2.1.1. Retroviral Vectors
5.3.2.1.2. Adeno-associated Virus Vectors
5.3.2.1.3. Other Viral Vectors
5.3.2.2. Non-viral Vector
5.3.2.2.1. Oligonucleotides
5.3.2.2.2. Other Non-viral Vectors

6. Cell and Gene Therapy Manufacturing Market: By Indication, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
6.3.1. Oncology Diseases
6.3.2. Cardiovascular Diseases
6.3.3. Orthopedic Diseases
6.3.4. Ophthalmology Diseases
6.3.5. Central Nervous System Disorders
6.3.6. Infectious Diseases
6.3.7. Other Indications

7. Cell and Gene Therapy Manufacturing Market: By Application, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2023 Versus 2032
7.3. Market Segmentation
7.3.1. Clinical Manufacturing
7.3.2. Commercial Manufacturing

8. Cell and Gene Therapy Manufacturing Market: By End User, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Growth & Revenue Analysis: 2023 Versus 2032
8.3. Market Segmentation
8.3.1. Pharmaceutical & Biotechnology Companies
8.3.2. Academic & Research Institutes
8.3.3. Other End Users


9. North America Cell and Gene Therapy Manufacturing Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Cell and Gene Therapy Manufacturing Market: By Type, 2022-2032, USD (Million)
9.3. Cell and Gene Therapy Manufacturing Market: By Indication, 2022-2032, USD (Million)
9.4. Cell and Gene Therapy Manufacturing Market: By Application, 2022-2032, USD (Million)
9.5. Cell and Gene Therapy Manufacturing Market: By End User, 2022-2032, USD (Million)
9.6.Cell and Gene Therapy Manufacturing Market: By Region, 2022-2032, USD (Million)
9.6.1.North America
9.6.1.1. U.S.
9.6.1.1.1. Cell and Gene Therapy Manufacturing Market: By Type, 2022-2032, USD (Million)
9.6.1.1.2. Cell and Gene Therapy Manufacturing Market: By Indication, 2022-2032, USD (Million)
9.6.1.1.3. Cell and Gene Therapy Manufacturing Market: By Application, 2022-2032, USD (Million)
9.6.1.1.4. Cell and Gene Therapy Manufacturing Market: By End User, 2022-2032, USD (Million)
9.6.1.2. Canada
9.6.1.2.1. Cell and Gene Therapy Manufacturing Market: By Type, 2022-2032, USD (Million)
9.6.1.2.2. Cell and Gene Therapy Manufacturing Market: By Indication, 2022-2032, USD (Million)
9.6.1.2.3. Cell and Gene Therapy Manufacturing Market: By Application, 2022-2032, USD (Million)
9.6.1.2.4. Cell and Gene Therapy Manufacturing Market: By End User, 2022-2032, USD (Million)
9.6.1.3. Rest of North America
9.6.1.3.1. Cell and Gene Therapy Manufacturing Market: By Type, 2022-2032, USD (Million)
9.6.1.3.2. Cell and Gene Therapy Manufacturing Market: By Indication, 2022-2032, USD (Million)
9.6.1.3.3. Cell and Gene Therapy Manufacturing Market: By Application, 2022-2032, USD (Million)
9.6.1.3.4. Cell and Gene Therapy Manufacturing Market: By End User, 2022-2032, USD (Million)

10. UK and European Union Cell and Gene Therapy Manufacturing Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Cell and Gene Therapy Manufacturing Market: By Type, 2022-2032, USD (Million)
10.3. Cell and Gene Therapy Manufacturing Market: By Indication, 2022-2032, USD (Million)
10.4. Cell and Gene Therapy Manufacturing Market: By Application, 2022-2032, USD (Million)
10.5. Cell and Gene Therapy Manufacturing Market: By End User, 2022-2032, USD (Million)
10.6.Cell and Gene Therapy Manufacturing Market: By Region, 2022-2032, USD (Million)
10.6.1.UK and European Union
10.6.1.1. UK
10.6.1.1.1. Cell and Gene Therapy Manufacturing Market: By Type, 2022-2032, USD (Million)
10.6.1.1.2. Cell and Gene Therapy Manufacturing Market: By Indication, 2022-2032, USD (Million)
10.6.1.1.3. Cell and Gene Therapy Manufacturing Market: By Application, 2022-2032, USD (Million)
10.6.1.1.4. Cell and Gene Therapy Manufacturing Market: By End User, 2022-2032, USD (Million)
10.6.1.2. Germany
10.6.1.2.1. Cell and Gene Therapy Manufacturing Market: By Type, 2022-2032, USD (Million)
10.6.1.2.2. Cell and Gene Therapy Manufacturing Market: By Indication, 2022-2032, USD (Million)
10.6.1.2.3. Cell and Gene Therapy Manufacturing Market: By Application, 2022-2032, USD (Million)
10.6.1.2.4. Cell and Gene Therapy Manufacturing Market: By End User, 2022-2032, USD (Million)
10.6.1.3. Spain
10.6.1.3.1. Cell and Gene Therapy Manufacturing Market: By Type, 2022-2032, USD (Million)
10.6.1.3.2. Cell and Gene Therapy Manufacturing Market: By Indication, 2022-2032, USD (Million)
10.6.1.3.3. Cell and Gene Therapy Manufacturing Market: By Application, 2022-2032, USD (Million)
10.6.1.3.4. Cell and Gene Therapy Manufacturing Market: By End User, 2022-2032, USD (Million)
10.6.1.4. Italy
10.6.1.4.1. Cell and Gene Therapy Manufacturing Market: By Type, 2022-2032, USD (Million)
10.6.1.4.2. Cell and Gene Therapy Manufacturing Market: By Indication, 2022-2032, USD (Million)
10.6.1.4.3. Cell and Gene Therapy Manufacturing Market: By Application, 2022-2032, USD (Million)
10.6.1.4.4. Cell and Gene Therapy Manufacturing Market: By End User, 2022-2032, USD (Million)
10.6.1.5. France
10.6.1.5.1. Cell and Gene Therapy Manufacturing Market: By Type, 2022-2032, USD (Million)
10.6.1.5.2. Cell and Gene Therapy Manufacturing Market: By Indication, 2022-2032, USD (Million)
10.6.1.5.3. Cell and Gene Therapy Manufacturing Market: By Application, 2022-2032, USD (Million)
10.6.1.5.4. Cell and Gene Therapy Manufacturing Market: By End User, 2022-2032, USD (Million)
10.6.1.6. Rest of Europe
10.6.1.6.1. Cell and Gene Therapy Manufacturing Market: By Type, 2022-2032, USD (Million)
10.6.1.6.2. Cell and Gene Therapy Manufacturing Market: By Indication, 2022-2032, USD (Million)
10.6.1.6.3. Cell and Gene Therapy Manufacturing Market: By Application, 2022-2032, USD (Million)
10.6.1.6.4. Cell and Gene Therapy Manufacturing Market: By End User, 2022-2032, USD (Million)

11. Asia Pacific Cell and Gene Therapy Manufacturing Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Cell and Gene Therapy Manufacturing Market: By Type, 2022-2032, USD (Million)
11.3. Cell and Gene Therapy Manufacturing Market: By Indication, 2022-2032, USD (Million)
11.4. Cell and Gene Therapy Manufacturing Market: By Application, 2022-2032, USD (Million)
11.5. Cell and Gene Therapy Manufacturing Market: By End User, 2022-2032, USD (Million)
11.6.Cell and Gene Therapy Manufacturing Market: By Region, 2022-2032, USD (Million)
11.6.1.Asia Pacific
11.6.1.1. China
11.6.1.1.1. Cell and Gene Therapy Manufacturing Market: By Type, 2022-2032, USD (Million)
11.6.1.1.2. Cell and Gene Therapy Manufacturing Market: By Indication, 2022-2032, USD (Million)
11.6.1.1.3. Cell and Gene Therapy Manufacturing Market: By Application, 2022-2032, USD (Million)
11.6.1.1.4. Cell and Gene Therapy Manufacturing Market: By End User, 2022-2032, USD (Million)
11.6.1.2. Japan
11.6.1.2.1. Cell and Gene Therapy Manufacturing Market: By Type, 2022-2032, USD (Million)
11.6.1.2.2. Cell and Gene Therapy Manufacturing Market: By Indication, 2022-2032, USD (Million)
11.6.1.2.3. Cell and Gene Therapy Manufacturing Market: By Application, 2022-2032, USD (Million)
11.6.1.2.4. Cell and Gene Therapy Manufacturing Market: By End User, 2022-2032, USD (Million)
11.6.1.3. India
11.6.1.3.1. Cell and Gene Therapy Manufacturing Market: By Type, 2022-2032, USD (Million)
11.6.1.3.2. Cell and Gene Therapy Manufacturing Market: By Indication, 2022-2032, USD (Million)
11.6.1.3.3. Cell and Gene Therapy Manufacturing Market: By Application, 2022-2032, USD (Million)
11.6.1.3.4. Cell and Gene Therapy Manufacturing Market: By End User, 2022-2032, USD (Million)
11.6.1.4. Australia
11.6.1.4.1. Cell and Gene Therapy Manufacturing Market: By Type, 2022-2032, USD (Million)
11.6.1.4.2. Cell and Gene Therapy Manufacturing Market: By Indication, 2022-2032, USD (Million)
11.6.1.4.3. Cell and Gene Therapy Manufacturing Market: By Application, 2022-2032, USD (Million)
11.6.1.4.4. Cell and Gene Therapy Manufacturing Market: By End User, 2022-2032, USD (Million)
11.6.1.5. South Korea
11.6.1.5.1. Cell and Gene Therapy Manufacturing Market: By Type, 2022-2032, USD (Million)
11.6.1.5.2. Cell and Gene Therapy Manufacturing Market: By Indication, 2022-2032, USD (Million)
11.6.1.5.3. Cell and Gene Therapy Manufacturing Market: By Application, 2022-2032, USD (Million)
11.6.1.5.4. Cell and Gene Therapy Manufacturing Market: By End User, 2022-2032, USD (Million)
11.6.1.6. Rest of Asia Pacific
11.6.1.6.1. Cell and Gene Therapy Manufacturing Market: By Type, 2022-2032, USD (Million)
11.6.1.6.2. Cell and Gene Therapy Manufacturing Market: By Indication, 2022-2032, USD (Million)
11.6.1.6.3. Cell and Gene Therapy Manufacturing Market: By Application, 2022-2032, USD (Million)
11.6.1.6.4. Cell and Gene Therapy Manufacturing Market: By End User, 2022-2032, USD (Million)

12. Latin America Cell and Gene Therapy Manufacturing Market, 2022-2032, USD (Million)
12.1. Market Overview
12.2. Cell and Gene Therapy Manufacturing Market: By Type, 2022-2032, USD (Million)
12.3. Cell and Gene Therapy Manufacturing Market: By Indication, 2022-2032, USD (Million)
12.4. Cell and Gene Therapy Manufacturing Market: By Application, 2022-2032, USD (Million)
12.5. Cell and Gene Therapy Manufacturing Market: By End User, 2022-2032, USD (Million)
12.6.Cell and Gene Therapy Manufacturing Market: By Region, 2022-2032, USD (Million)
12.6.1.Latin America
12.6.1.1. Brazil
12.6.1.1.1. Cell and Gene Therapy Manufacturing Market: By Type, 2022-2032, USD (Million)
12.6.1.1.2. Cell and Gene Therapy Manufacturing Market: By Indication, 2022-2032, USD (Million)
12.6.1.1.3. Cell and Gene Therapy Manufacturing Market: By Application, 2022-2032, USD (Million)
12.6.1.1.4. Cell and Gene Therapy Manufacturing Market: By End User, 2022-2032, USD (Million)
12.6.1.2. Mexico
12.6.1.2.1. Cell and Gene Therapy Manufacturing Market: By Type, 2022-2032, USD (Million)
12.6.1.2.2. Cell and Gene Therapy Manufacturing Market: By Indication, 2022-2032, USD (Million)
12.6.1.2.3. Cell and Gene Therapy Manufacturing Market: By Application, 2022-2032, USD (Million)
12.6.1.2.4. Cell and Gene Therapy Manufacturing Market: By End User, 2022-2032, USD (Million)
12.6.1.3. Rest of Latin America
12.6.1.3.1. Cell and Gene Therapy Manufacturing Market: By Type, 2022-2032, USD (Million)
12.6.1.3.2. Cell and Gene Therapy Manufacturing Market: By Indication, 2022-2032, USD (Million)
12.6.1.3.3. Cell and Gene Therapy Manufacturing Market: By Application, 2022-2032, USD (Million)
12.6.1.3.4. Cell and Gene Therapy Manufacturing Market: By End User, 2022-2032, USD (Million)

13. Middle East and Africa Cell and Gene Therapy Manufacturing Market, 2022-2032, USD (Million)
13.1. Market Overview
13.2. Cell and Gene Therapy Manufacturing Market: By Type, 2022-2032, USD (Million)
13.3. Cell and Gene Therapy Manufacturing Market: By Indication, 2022-2032, USD (Million)
13.4. Cell and Gene Therapy Manufacturing Market: By Application, 2022-2032, USD (Million)
13.5. Cell and Gene Therapy Manufacturing Market: By End User, 2022-2032, USD (Million)
13.6.Cell and Gene Therapy Manufacturing Market: By Region, 2022-2032, USD (Million)
13.6.1.Middle East and Africa
13.6.1.1. GCC
13.6.1.1.1. Cell and Gene Therapy Manufacturing Market: By Type, 2022-2032, USD (Million)
13.6.1.1.2. Cell and Gene Therapy Manufacturing Market: By Indication, 2022-2032, USD (Million)
13.6.1.1.3. Cell and Gene Therapy Manufacturing Market: By Application, 2022-2032, USD (Million)
13.6.1.1.4. Cell and Gene Therapy Manufacturing Market: By End User, 2022-2032, USD (Million)
13.6.1.2. Africa
13.6.1.2.1. Cell and Gene Therapy Manufacturing Market: By Type, 2022-2032, USD (Million)
13.6.1.2.2. Cell and Gene Therapy Manufacturing Market: By Indication, 2022-2032, USD (Million)
13.6.1.2.3. Cell and Gene Therapy Manufacturing Market: By Application, 2022-2032, USD (Million)
13.6.1.2.4. Cell and Gene Therapy Manufacturing Market: By End User, 2022-2032, USD (Million)
13.6.1.3. Rest of Middle East and Africa
13.6.1.3.1. Cell and Gene Therapy Manufacturing Market: By Type, 2022-2032, USD (Million)
13.6.1.3.2. Cell and Gene Therapy Manufacturing Market: By Indication, 2022-2032, USD (Million)
13.6.1.3.3. Cell and Gene Therapy Manufacturing Market: By Application, 2022-2032, USD (Million)
13.6.1.3.4. Cell and Gene Therapy Manufacturing Market: By End User, 2022-2032, USD (Million)

14. Company Profile
14.1. Novartis AG
14.1.1. Company Overview
14.1.2. Financial Performance
14.1.3. Product Portfolio
14.1.4. Strategic Initiatives
14.2. Kite Pharma
14.2.1. Company Overview
14.2.2. Financial Performance
14.2.3. Product Portfolio
14.2.4. Strategic Initiatives
14.3. Spark Therapeutics
14.3.1. Company Overview
14.3.2. Financial Performance
14.3.3. Product Portfolio
14.3.4. Strategic Initiatives
14.4. Bluebird Bio
14.4.1. Company Overview
14.4.2. Financial Performance
14.4.3. Product Portfolio
14.4.4. Strategic Initiatives
14.5. CRISPR Therapeutics
14.5.1. Company Overview
14.5.2. Financial Performance
14.5.3. Product Portfolio
14.5.4. Strategic Initiatives
14.6. Lonza
14.6.1. Company Overview
14.6.2. Financial Performance
14.6.3. Product Portfolio
14.6.4. Strategic Initiatives
14.7. Catalent Inc.
14.7.1. Company Overview
14.7.2. Financial Performance
14.7.3. Product Portfolio
14.7.4. Strategic Initiatives
14.8. F. Hoffmann-La Roche Ltd.
14.8.1. Company Overview
14.8.2. Financial Performance
14.8.3. Product Portfolio
14.8.4. Strategic Initiatives
14.9. Samsung Biologics
14.9.1. Company Overview
14.9.2. Financial Performance
14.9.3. Product Portfolio
14.9.4. Strategic Initiatives
14.10. Boehringer Ingelheim
14.10.1. Company Overview
14.10.2. Financial Performance
14.10.3. Product Portfolio
14.10.4. Strategic Initiatives
14.11. Cellular Therapeutics
14.11.1. Company Overview
14.11.2. Financial Performance
14.11.3. Product Portfolio
14.11.4. Strategic Initiatives
14.12. Hitachi Chemical Co., Ltd.
14.12.1. Company Overview
14.12.2. Financial Performance
14.12.3. Product Portfolio
14.12.4. Strategic Initiatives
14.13. Takara Bio Inc.
14.13.1. Company Overview
14.13.2. Financial Performance
14.13.3. Product Portfolio
14.13.4. Strategic Initiatives
14.14. Miltenyi Biotec
14.14.1. Company Overview
14.14.2. Financial Performance
14.14.3. Product Portfolio
14.14.4. Strategic Initiatives
14.15. Thermo Fisher Scientific
14.15.1. Company Overview
14.15.2. Financial Performance
14.15.3. Product Portfolio
14.15.4. Strategic Initiatives
14.16. Merck KGaA
14.16.1. Company Overview
14.16.2. Financial Performance
14.16.3. Product Portfolio
14.16.4. Strategic Initiatives
14.17. Other Notable Players
14.17.1. Company Overview
14.17.2. Financial Performance
14.17.3. Product Portfolio
14.17.4. Strategic Initiatives